• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[常温心脏停搏液联合磷酸肌酸保护心肌免受缺血损伤的有效性]

[Effectiveness of protecting the myocardium against ischemia with a normothermic cardioplegic solution and creatine phosphate].

作者信息

Popov Iu V, Saprygin D B, Egorova I F, Kashtélian L S, Bakuleva N P

出版信息

Biull Eksp Biol Med. 1985 Jan;99(1):108-10.

PMID:3967061
Abstract

The protective effects of cardioplegic solutions (CS) containing creatine phosphate (CP) were studied in a rat heart model of cardiopulmonary bypass and ischemic cardiac arrest. Isolated rat hearts were subjected to a 3-minute coronary infusion with CS containing CP in normothermic (37 degrees C) and hypothermic (4-6 degrees C) regimes. In the normothermia group, the postischemic functional recovery was 70-75% of the preischemic control value, while the cellular ATP and CP content was reduced but insignificantly. By contrast, in the hypothermia group, the postischemic functional recovery was markedly depressed, with the tissue high-energy phosphate content being appreciably lowered. The data obtained confirm high efficacy of CP-containing cardioplegic solutions administered under normothermia conditions.

摘要

在大鼠体外循环和缺血性心脏骤停模型中,研究了含磷酸肌酸(CP)的心脏停搏液(CS)的保护作用。将离体大鼠心脏在常温(37℃)和低温(4 - 6℃)条件下用含CP的CS进行3分钟冠状动脉灌注。在常温组中,缺血后功能恢复为缺血前对照值的70 - 75%,而细胞ATP和CP含量降低但不显著。相比之下,在低温组中,缺血后功能恢复明显受抑,组织高能磷酸含量明显降低。所获数据证实了在常温条件下给予含CP心脏停搏液的高效性。

相似文献

1
[Effectiveness of protecting the myocardium against ischemia with a normothermic cardioplegic solution and creatine phosphate].[常温心脏停搏液联合磷酸肌酸保护心肌免受缺血损伤的有效性]
Biull Eksp Biol Med. 1985 Jan;99(1):108-10.
2
The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the rat.
J Thorac Cardiovasc Surg. 1980 Jan;79(1):39-43.
3
Enhanced myocardial protection with high-energy phosphates in St. Thomas' Hospital cardioplegic solution. Synergism of adenosine triphosphate and creatine phosphate.圣托马斯医院心脏停搏液中高能磷酸盐增强心肌保护作用。三磷酸腺苷与磷酸肌酸的协同作用。
J Thorac Cardiovasc Surg. 1987 Mar;93(3):415-27.
4
Creatine phosphate: an additive myocardial protective and antiarrhythmic agent in cardioplegia.磷酸肌酸:心脏停搏液中一种附加的心肌保护和抗心律失常药物。
J Thorac Cardiovasc Surg. 1984 Feb;87(2):190-200.
5
Influence of the pH of cardioplegic solutions on intracellular pH, high-energy phosphates, and postarrest performance. Protective effects of acidotic, glutamate-containing cardioplegic perfusates.心脏停搏液pH值对细胞内pH值、高能磷酸盐及停搏后心脏功能的影响。含谷氨酸的酸性心脏停搏灌注液的保护作用。
J Thorac Cardiovasc Surg. 1985 Aug;90(2):235-42.
6
The temperature dependence of recovery of metabolic function following hypothermic potassium cardioplegic arrest.
J Thorac Cardiovasc Surg. 1982 Jan;83(1):117-21.
7
The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the dog.低温与化学心脏停搏在犬缺血性心脏骤停期间的相加保护作用。
J Thorac Cardiovasc Surg. 1980 Jan;79(1):29-38.
8
Protection of the chronic hypoxic immature rat heart during global ischemia.在全心缺血期间对慢性缺氧未成熟大鼠心脏的保护作用。
Ann Thorac Surg. 1995 Mar;59(3):699-706. doi: 10.1016/0003-4975(94)01015-3.
9
Effect of increasing volume of cardioplegic solution on postischemic myocardial recovery.增加心脏停搏液体积对缺血后心肌恢复的影响。
J Thorac Cardiovasc Surg. 1987 Aug;94(2):234-40.
10
Steroids and cardioplegia. An experimental evaluation of glucocorticoid supplementation to cardioplegic solutions in clinical use.类固醇与心脏停搏液。临床使用的心脏停搏液中补充糖皮质激素的实验评估。
Thorac Cardiovasc Surg. 1985 Apr;33(2):65-70. doi: 10.1055/s-2007-1014090.